Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2025

SELL
$87.78 - $105.45 $209,969 - $252,236
-2,392 Closed
0 $0
Q3 2023

Feb 13, 2025

BUY
$90.94 - $199.54 $92,667 - $203,331
1,019 Added 74.22%
2,392 $218 Million
Q2 2023

Feb 13, 2025

BUY
$155.98 - $172.65 $4,211 - $4,661
27 Added 2.01%
1,373 $222 Million
Q1 2023

Feb 13, 2025

BUY
$132.34 - $159.14 $178,129 - $214,202
1,346 New
1,346 $214 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $176B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.